Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRL | DHR | HCA | CVS | ELV |
| Company | Charles River Laboratories Intl | Danaher Corp | Hca Holdings Inc | CVS Corp | Elevance Health Inc |
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | NYSE | NYSE |
| Open | 184.39 | 224.87 | 486.70 | 75.95 | 332.02 |
| High | 189.15 | 226.76 | 490.07 | 76.95 | 332.07 |
| Low | 183.43 | 223.43 | 483.25 | 75.00 | 323.04 |
| Latest | 187.50 | 223.54 | 487.39 | 76.20 | 330.76 |
| Change | +3.19 | -2.71 | +0.69 | +0.57 | +0.01 |
| % Change | +1.73% | -1.20% | +0.14% | +0.75% | unch |
| Volume | 400,367 | 1,367,592 | 494,467 | 3,786,289 | 733,701 |
| 20-Day Average Volume | 918,054 | 3,615,911 | 1,338,721 | 6,817,950 | 1,533,716 |
| Previous Close | 184.31 | 226.25 | 486.70 | 75.63 | 330.75 |
| Industry | Medical Services | Medical Services | Medical Services | Medical Services | Medical Services |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 173.24 | 223.81 | 486.80 | 77.93 | 326.87 |
| 20-Day Raw Stochastic | 96.12% | 66.07% | 56.52% | 28.50% | 73.03% |
| 20-Day Relative Strength | 61.72 | 55.58 | 57.99 | 46.35 | 51.04 |
| Weighted Alpha | +20.38 | +1.97 | +60.54 | +45.89 | -13.92 |
| Today's Opinion | 88% Buy | 100% Buy | 100% Buy | 40% Buy | 40% Sell |
| Previous Opinion | 88% Buy | 100% Buy | 100% Buy | 40% Buy | 40% Sell |
| Last Month's Opinion | 80% Buy | 88% Buy | 100% Buy | 80% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.60% since 12/01/25 | -0.07% since 12/01/25 | -3.20% since 12/01/25 | -3.54% since 12/01/25 | +0.34% since 12/01/25 |
| Low | 172.95 on 12/02/25 | 223.76 on 12/04/25 | 483.27 on 12/08/25 | 74.14 on 12/04/25 | 323.43 on 12/08/25 |
| High | 188.96 on 12/08/25 | 230.65 on 12/03/25 | 508.28 on 12/02/25 | 79.43 on 12/02/25 | 336.45 on 12/04/25 |
| 1-Month | |||||
| %Chg | +11.70% since 11/07/25 | +6.69% since 11/07/25 | +2.16% since 11/07/25 | -3.41% since 11/07/25 | +4.10% since 11/07/25 |
| Low | 156.72 on 11/19/25 | 207.72 on 11/10/25 | 443.87 on 11/10/25 | 74.14 on 12/04/25 | 300.81 on 11/10/25 |
| High | 188.96 on 12/08/25 | 232.35 on 11/25/25 | 520.00 on 11/26/25 | 81.72 on 11/12/25 | 341.89 on 11/26/25 |
| 3-Month | |||||
| %Chg | +15.87% since 09/08/25 | +12.77% since 09/08/25 | +16.45% since 09/08/25 | +8.60% since 09/08/25 | +7.35% since 09/08/25 |
| Low | 144.26 on 09/25/25 | 180.03 on 09/25/25 | 385.58 on 09/10/25 | 70.72 on 09/09/25 | 300.81 on 11/10/25 |
| High | 199.66 on 10/24/25 | 234.99 on 10/21/25 | 520.00 on 11/26/25 | 85.15 on 10/29/25 | 364.87 on 10/09/25 |
| 6-Month | |||||
| %Chg | +29.72% since 06/06/25 | +14.27% since 06/06/25 | +26.68% since 06/06/25 | +20.01% since 06/06/25 | -15.90% since 06/06/25 |
| Low | 143.06 on 06/18/25 | 180.03 on 09/25/25 | 330.00 on 07/25/25 | 58.50 on 07/24/25 | 273.71 on 08/06/25 |
| High | 199.66 on 10/24/25 | 234.99 on 10/21/25 | 520.00 on 11/26/25 | 85.15 on 10/29/25 | 400.53 on 07/01/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 9,070,816 | 159,811,680 | 111,062,016 | 96,007,136 | 73,505,544 |
| Shares Outstanding, K | 49,215 | 706,350 | 228,194 | 1,269,432 | 222,239 |
| Annual Sales | 4,049,990,000 | 23,875,000,000 | 70,603,000,000 | 372,809,000,000 | 177,011,000,000 |
| Annual Net Income | 22,200,000 | 3,899,000,000 | 5,760,000,000 | 4,614,000,000 | 5,980,000,000 |
| Last Quarter Sales | 1,004,850,000 | 6,053,000,000 | 19,161,000,000 | 102,871,000,000 | 50,711,000,000 |
| Last Quarter Net Income | 54,420,000 | 908,000,000 | 1,643,000,000 | -3,975,000,000 | 1,189,000,000 |
| 60-Month Beta | 1.63 | 0.89 | 1.36 | 0.48 | 0.52 |
| Per-Share Information | |||||
| Most Recent Earnings | 2.43 on 11/05/25 | 1.89 on 10/21/25 | 6.96 on 10/24/25 | 1.60 on 10/29/25 | 6.03 on 10/21/25 |
| Latest Earnings Date | 11/05/25 | 10/21/25 | 01/23/26 | 10/29/25 | 01/22/26 |
| Most Recent Dividend | N/A | 0.320 on 09/26/25 | 0.720 on 09/16/25 | 0.665 on 10/23/25 | 1.710 on 12/05/25 |
| Next Ex-Dividends Date | N/A | 09/26/25 | 12/15/25 | 10/23/25 | 12/05/25 |
| Ratios | |||||
| Price/Earnings ttm | 17.44 | 29.46 | 18.42 | 11.20 | 10.87 |